HOME >> BIOLOGY >> NEWS
Yale and Alexion report advance in spinal cord repair

NAGOYA, JAPAN, Oct. 25, 1999 -- Researchers from the Yale University School of Medicine and Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported that transplanting genetically modified pig cells into surgically damaged spinal cords of non-human primates can regenerate the myelin sheath around the injured fragment of the spinal cord. Alexion believes that these results represent a critical milestone in progressing its spinal cord product into patient trials.

The report, entitled "Xenotransplantation of Transgenic Pig Myelin Forming Cells Promotes Axonal Regeneration and Restores Conduction Across the Transected Spinal Cord," is based on research conducted in the laboratories of Dr. Jeffrey D. Kocsis of the Department of Neurology, Yale University School of Medicine, and Dr. William L. Fodor, Senior Director of Xenotransplantation at Alexion Pharmaceuticals, Inc. and their colleagues.

"This promising data demonstrates that immunoprotected transgenic pig cells can survive and regenerate myelin sheaths around damaged neurons within the spinal cords of non-human primates," said Stephen Squinto, Senior Vice President and Chief Technology Officer of Alexion. "Together with our findings also presented today which showed that these transgenic pig cells both engraft and restore electrical conductance in rodent models of spinal injury, these data suggest that this approach may lead to the development of a new therapy for spinal cord injury patients."

Specific antibody binding to the surface of a foreign cell initiates a process called the "complement" cascade, which results in the destruction of the foreign cell. Complement-mediated rejection of nerve cell xenografts presents a major obstacle to effectively replacing damaged cells in the central nervous system. Alexion scientists address this problem in two ways. First, they produce pig cells that reduce or eliminate the expression of certain pig sugars which are targeted by the triggering antibod
'"/>

Contact: Tom Baker
t.baker@noonanrusso.com
212-696-4455 Ext 205
Noonan/Russo Communications
24-Oct-1999


Page: 1 2 3

Related biology news :

1. Alexion and Yale discover harmful complement activation in patients with acute coronary syndrome
2. Harvard and Alexion researchers report successful transplantation of immuneprotected neurons in primate model of Parkinsons disease
3. March of Dimes statement on newborn screening report
4. Researchers report new gene test for isolated cleft lip and palate
5. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
6. Unicellular organisms contribute more nitrogen to ocean that reported earlier
7. Researchers report new gene test for isolated cleft lip and palate
8. British scientists exclude maverick colleagues, says report
9. New public policy & aging report highlights facts and fiction about anti-aging medicine
10. APP reports Abraxane(TM) is active in breast cancer patients who failed taxol or taxotere
11. Researchers report major advance in gene therapy technique

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... ... February 06, 2020 , ... Kerafast Inc. ... bioresearch materials, today announced an agreement with The Good Food Institute , ... reality. Under the partnership, terrestrial meat and aquatic cell lines will be made ...
(Date:1/30/2020)... Ontario (PRWEB) , ... January 30, 2020 , ... ... with an eye on the Canadian market, is pleased to announce that the company ... of growth since the company launched in 2017. , “We are so thrilled ...
(Date:1/28/2020)... OF PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... dedicated to solving complex problems for life sciences companies and government agencies, announced ... largest life sciences hubs in the country. Tunnell’s Cambridge office will be in ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... ... February 20, 2020 , ... The dietary ... reassuring consumers that what’s listed on an ingredient panel is actually in their ... this solution with the adoption of CertainT, which is designed to protect the ...
(Date:2/19/2020)... ... 2020 , ... Intech , the leader in contract ... unified global brand identity, as it celebrates its 20th anniversary. , Fueled by ... an enthusiasm for designing and manufacturing state-of-the-art medical devices, Intech has grown leaps ...
(Date:2/11/2020)... , ... February 11, 2020 , ... ... residuals solutions services in North America, today announced that the City of Fort ... to its biosolids management needs. Commencing in April of 2020, Synagro will assume ...
(Date:2/3/2020)... YORK (PRWEB) , ... February 03, 2020 , ... ... Business Travel, Financial Services Firm Travel, Law Firm Travel, Technology Industry Travel and ... data findings, listed quarterly. Each Index illustrates the following statistics:, ...
Breaking Biology Technology:
Cached News: